What we fund
High-impacthealth investments
A global grant-making platform
We don’t believe in one-off solutions. Instead, we invest in projects and programmes that are scalable, can be sustained for the long-term, and that have the power to unlock catalytic health impact.
Grants are currently focused on the elimination of hepatitis B (HBV) and hepatitis C (HCV) in countries where governments are demonstrably committed to hepatitis elimination. Priority regions include Asia-Pacific and Africa, where the burden of viral hepatitis is greatest.
OUR PRIORITIES
Funding to eliminate viral hepatitis
We prioritise projects and partners that:
Unlock
public health impact
Promote
systemic changes
Deliver
proof-of-concept
PROGRAMMACTIC AREAS
A cross-cutting approach
Part of a global move towards Universal Health Coverage, we support initiatives that align with the WHO Global Health Sector Strategy and close critical gaps in national plans for the elimination of viral hepatitis.
Policy
Epidemiology
Economics & finance
Human resources for health
Biomedical prevention
Screening, testing & diagnostics
Treatment &
cure
DEMONSTRATING IMPACT
Monitoring and
Evaluation
Our unique Monitoring and Evaluation framework allows us for real-time learning and course-correcting actions. It also acts as a rubric for overall project evaluation to help us demonstrate the case for change and invest strategically.
OUR GRANT MAKING PRACTICE
Sustainable.Impactful.
All funds are allocated based on a careful evaluation by a team of experts and sit in line with our principles of best grant-making practices.
The Hepatitis Fund does not accept unsolicited applications.
Photo credit: CHAI/McNab; THF/Olivier Mugwiza.